[Pharmacological studies on the new antihistaminic Tavegil].
D000707:Anaphylaxis / Q000188:drug therapy*; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D011759:Pyrrolidines / Q000627:therapeutic use*
D006634:Histamine H1 Antagonists; D011759:Pyrrolidines
Pharmakologische Studien über das neue Antihistaminicum Tavegil.